<DOC>
	<DOC>NCT00470873</DOC>
	<brief_summary>The primary aim of this open, uncontrolled, prospective, non-interventional post-marketing surveillance study is to obtain data on safety and efficacy of Levitra in routine treatment of erectile dysfunction. The secondary aim of this study is to assess the influence of the treatment with Levitra on self-esteem (depressive symptomology) in men with ED.</brief_summary>
	<brief_title>Vardenafil Treatment Of Erectile Dysfunction In Depressive And Non-Depressive Men</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Vardenafil Dihydrochloride</mesh_term>
	<criteria>Age over 18 Erectile dysfunction untreated or ineffectively treated with other than vardenafil PDE5 inhibitors Treatment with nitrates Allergy to vardenafil or other tablets ingredients Treatment with CYP3A4 inhibitors (e.g. indinavir, ritonavir, ketoconazole, itraconazole, erythromycin) Cardiovascular status excluding any sexual activity</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>